Intrinsic Value

The intrinsic value of Remgro Ltd (RE7) under the Base Case is 8.24 EUR per share. Compared with the current market price of 11.2 EUR, the stock appears Overvalued by 26% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

RE7 Intrinsic Value
€8.24
Overvaluation 26%
Intrinsic Value
Price €11.2
R

RE7 is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor RE7
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €6.59
Get notified when the price drops into your buy zone
Current Price €11.2
Intrinsic Value €8.24
Margin of Safety 20% €6.59
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to RE7

Fundamental Analysis

What Remgro Does

Financial Services Financials

Remgro is a South African investment holding company. It does not sell a single product itself; instead, it owns shares in a group of operating businesses across areas such as healthcare, consumer goods, insurance, telecommunications, and infrastructure. Its main job is to own, manage, and grow these investments over time.

Headquarters
South Africa ZA
Employees
46
IPO date
Sep 26, 2000
Read the full company overview
View Company Overview

Remgro has no economic moat

No Moat Narrow Wide

Investors can move their money to other listed holding companies or buy shares in listed investees directly, without losing a Remgro-only service or network. Its broad portfolio does not by itself make customers depend on Remgro or give it a reason to charge more than alternatives.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Remgro Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one RE7 stock?

The intrinsic value for Remgro Ltd (RE7) under the Base Case is 8.24 EUR.

Is RE7 stock undervalued or overvalued?

Compared with the current market price of 11.2 EUR, the stock appears Overvalued by 26% .

Back to Top